Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NexgenRx Inc (TSE:NXG)
TSXV:NXG
NexgenRx (NXG) Financial Statements
10 Followers
NexgenRx Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | C$ 3.39M | C$ 3.42M | C$ 3.46M | C$ 3.20M | C$ 3.32M |
| Gross Profit | C$ 2.66M | C$ 2.67M | C$ 2.74M | C$ 2.70M | C$ 2.47M |
| EBIT | C$ -112.94K | C$ 8.46K | C$ 212.77K | C$ -140.38K | C$ -87.46K |
| EBITDA | C$ 209.09K | C$ 344.93K | C$ 582.83K | - | C$ 237.96K |
| Net Income Common Stockholders | C$ -130.73K | C$ -8.59K | C$ 194.93K | C$ -365.82K | C$ -64.61K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | C$ 1.94M | C$ 1.27M | C$ 1.26M | C$ 1.77M | C$ 1.99M |
| Total Assets | C$ 29.44M | C$ 28.85M | C$ 28.60M | C$ 25.75M | C$ 29.40M |
| Total Debt | C$ 399.28K | C$ 410.48K | C$ 421.55K | C$ 432.47K | C$ 559.90K |
| Net Debt | C$ -1.54M | C$ -859.15K | C$ -842.79K | C$ -1.33M | C$ -1.43M |
| Total Liabilities | C$ 20.93M | C$ 20.25M | C$ 19.58M | C$ 16.90M | C$ 20.16M |
| Stockholders Equity | C$ 8.51M | C$ 8.60M | C$ 9.02M | C$ 8.85M | C$ 9.24M |
| Cash Flow | - | ||||
| Free Cash Flow | C$ 655.41K | C$ 440.29K | C$ -464.16K | C$ -167.03K | C$ 649.65K |
| Operating Cash Flow | C$ 708.69K | C$ 617.24K | C$ -378.41K | C$ -483.82K | C$ 1.29M |
| Investing Cash Flow | C$ -53.28K | C$ -176.95K | C$ -85.75K | C$ 316.79K | C$ -640.22K |
| Financing Cash Flow | C$ 12.21K | C$ -435.00K | C$ -460.22K | C$ -59.90K | C$ -447.92K |
NexgenRx Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.